Mechanisms of Weight Loss after Gastric Bypass and Gastric Banding

被引:26
作者
Bueter, Marco [1 ]
Ashrafian, Hutan [1 ]
le Roux, Carel W. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Invest Med, London W12 0NN, England
关键词
Obesity; Gut hormones; Gastric bypass; Hypothalamus; Appetite; Satiety; GLUCAGON-LIKE PEPTIDE-1; PLASMA GHRELIN LEVELS; INCREASES FOOD-INTAKE; BARIATRIC SURGERY; BODY-WEIGHT; INHIBITORY POLYPEPTIDE; OBESE SUBJECTS; GUT HORMONE; NEUROPEPTIDE-Y; POSTPRANDIAL GLUCOSE;
D O I
10.1159/000232383
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The obesity epidemic is a major health problem that is associated with increased morbidity and mortality. Gastrointestinal hormones have been increasingly understood to be an important element in appetite regulation. Several gastrointestinal hormones can contribute to obesity by modulating the activity of the gut-brain axis. Bariatric surgery is currently the most effective therapy for significant and sustained weight loss in morbidly obese patients. Understanding how gut hormones are altered by bariatric procedures has contributed to our understanding of the mechanisms of appetite. In this review, we address several gastrointestinal hormones that are associated with obesity and consider how their levels are altered after bariatric surgery. The review also addresses specific effects of different gut hormones on appetite, hunger, and energy balance.
引用
收藏
页码:325 / 331
页数:7
相关论文
共 93 条
  • [1] The inhibitory effects of peripheral administration of peptide YY3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway
    Abbott, CR
    Monteiro, M
    Small, CJ
    Sajedi, A
    Smith, KL
    Parkinson, JRC
    Ghatei, MA
    Bloom, SR
    [J]. BRAIN RESEARCH, 2005, 1044 (01) : 127 - 131
  • [2] Long-term mortality after gastric bypass surgery
    Adams, Ted D.
    Gress, Richard E.
    Smith, Sherman C.
    Halverson, R. Chad
    Simper, Steven C.
    Rosamond, Wayne D.
    LaMonte, Michael J.
    Stroup, Antoinette M.
    Hunt, Steven C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (08) : 753 - 761
  • [3] PEPTIDE-YY ABNORMALITIES IN GASTROINTESTINAL-DISEASES
    ADRIAN, TE
    SAVAGE, AP
    BACARESEHAMILTON, AJ
    WOLFE, K
    BESTERMAN, HS
    BLOOM, SR
    [J]. GASTROENTEROLOGY, 1986, 90 (02) : 379 - 384
  • [4] HUMAN DISTRIBUTION AND RELEASE OF A PUTATIVE NEW GUT HORMONE, PEPTIDE-YY
    ADRIAN, TE
    FERRI, GL
    BACARESEHAMILTON, AJ
    FUESSL, HS
    POLAK, JM
    BLOOM, SR
    [J]. GASTROENTEROLOGY, 1985, 89 (05) : 1070 - 1077
  • [5] PEPTIDE YY (PYY) IMMUNOREACTIVITY IS CO-STORED WITH GLUCAGON-RELATED IMMUNOREACTANTS IN ENDOCRINE-CELLS OF THE GUT AND PANCREAS
    ALIRACHEDI, A
    VARNDELL, IM
    ADRIAN, TE
    GAPP, DA
    VANNOORDEN, S
    BLOOM, SR
    POLAK, JM
    [J]. HISTOCHEMISTRY, 1984, 80 (05) : 487 - 491
  • [6] EFFECTS OF PEPTIDE-YY AND NEUROPEPTIDE-Y ON GASTRIC-EMPTYING IN MAN
    ALLEN, JM
    FITZPATRICK, ML
    YEATS, JC
    DARCY, K
    ADRIAN, TE
    BLOOM, SR
    [J]. DIGESTION, 1984, 30 (04) : 255 - 262
  • [7] Obesity in North America - An overview
    Allison, DB
    Saunders, SE
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2000, 84 (02) : 305 - +
  • [8] Antagonism of ghrelin receptor reduces food intake and body weight gain in mice
    Asakawa, A
    Inui, A
    Kaga, T
    Katsuura, G
    Fujimiya, M
    Fujino, MA
    Kasuga, M
    [J]. GUT, 2003, 52 (07) : 947 - 952
  • [9] Biology of incretins: GLP-1 and GIP
    Baggio, Laurie L.
    Drucker, Daniel J.
    [J]. GASTROENTEROLOGY, 2007, 132 (06) : 2131 - 2157
  • [10] Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36):: Development of an anorectic Y4 receptor selective agonist with picomolar affinity
    Balasubramaniam, A
    Mullins, DE
    Lin, S
    Zhai, W
    Tao, ZY
    Dhawan, VC
    Guzzi, M
    Knittel, JJ
    Slack, K
    Herzog, H
    Parker, EM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (08) : 2661 - 2665